NCI Corner

Articles from the US National Cancer Institute about issues relevant to the field of thoracic oncology.

NCI Corner – Interview with Jeff Abrams

NCI Helping to Save Lives and Improve Cancer Survival Rates Scientific data from clinical trials are essential for evaluating new cancer treatments and setting new...

The Budget Landscape with Dr. Douglas R. Lowy

By Erik MacLaren, PhD The National Cancer Institute (NCI) and researchers who rely on the funding it provides have spent much of the past year...

Discussing ALCHEMIST with Shakun Malik, MD

Patients with completely resected early-stage non-small cell lung cancer (NSCLC) have approximately a 50% chance of experiencing disease recurrence following standard treatment. In 2014,...

NCI Selects Five Teams of Researchers to Expand Discovery of Predictive Biomarkers for Immunotherapy

In October 2017, the United States National Cancer Institute (NCI) launched a major effort to expand the discovery and validation of predictive biomarkers on...

NCI Corner – Interview with Shakun Malik, MD

By Erik J. Mac Laren, PhD In late 2015, the US National Cancer Institute (NCI) Thoracic Malignancy Steering Committee (TMSC) published its strategic priorities for...

NCI Corner: Racial Differences in the Transcriptomes of Lung Tumors

Investigators at the National Cancer Institute (NCI) compared the transcriptional profiles of lung cancers from African American patients to those from white patients and...

Small Cell Lung Cancer: The Next Challenge

By Peter Ujhazy, MD, PhD The newfound optimism in the management of lung cancer that infused the research, clinical, and patient communities 12 years ago...

NCI Corner – Interview with Dinah S. Singer, PHD

By Erik J. MacLaren, PhD Blue Ribbon Panel of the US National Cancer Advisory Board During his State of the Union address in January 2016, President...

Meeting News